Envestnet Asset Management
RDHL

Envestnet Asset Management’s Redhill Biopharma RDHL Stock Holding History

Envestnet Asset Management’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-71
Closed -$9.89K – 4082
2022
Q4 		$9.89K Buy
71
+46
+184% +$19.9K ﹤0.01% 3939
2022
Q3 		$13K Buy
+25
New +$21.8K ﹤0.01% 3880
2021
Q4 		– Sell
-77
Closed -$354K – 3934
2021
Q3 		$354K Buy
+77
New +$522K ﹤0.01% 3193

Other funds holding RDHL

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Envestnet Asset Management's RDHL Position: Q1 2023 in Review

Envestnet Asset Management sold out of Redhill Biopharma (RDHL) in Q1 2023, closing a stake of 71 shares — an estimated $9.89K sold.

Envestnet Asset Management first reported a position in RDHL in Q3 2021 and held it in 3 quarters. The position peaked at $354K in Q3 2021. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2023.

  • Envestnet Asset Management reported no remaining Redhill Biopharma position as of Q1 2023 after selling out during the quarter.
  • Envestnet Asset Management sold 71 Redhill Biopharma shares in Q1 2023, an estimated $9.89K.
  • Envestnet Asset Management first reported a position in Redhill Biopharma in Q3 2021 and held it in 3 quarters.
  • Envestnet Asset Management's Redhill Biopharma position peaked at $354K in Q3 2021.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2023.

Based on Envestnet Asset Management's 13F filing for Q1 2023, filed 11 May 2023.